“…While several animal studies found that SOD1 could reduce infarction in both regional (Gross et al, 1986; Hangaishi et al, 2001; Kanamasa et al, 2001) and global heart ischemia (Ambrosio and Flaherty, 1992; Nishikawa et al, 1991; Otani et al, 1986; Wang et al, 1998), others found that it failed to protect against infarction in various ischemia models (Gallagher et al, 1986; Jones et al, 2003; Klein et al, 1988; Matsuda et al, 1991; Nejima et al, 1989; Ooiwa et al, 1991; Patel et al, 1990; Przyklenk and Kloner, 1989; Richard et al, 1988; Uraizee et al, 1987; Watanabe et al, 1993). Downey et al suggested that SOD1 might interfere with the ability of TTC to differentiate between living and dead cells (Downey et al, 1991), with the result that TTC produced an artifactually reduced infarct size in SOD1-treated animals (Shirato et al, 1989).…”